Metronidazole Intravenous (IV) Infusion (5 mg / ml)
Healthy Inc is a specialized global supplier and exporter of advanced anti-infectives, critical care, and surgical therapeutics. We provide ultra-high-purity, sterile Metronidazole Infusions, manufactured in WHO–GMP certified, high-precision large volume parenteral (LVP) facilities. This “Nitroimidazole Antibacterial & Antiprotozoal” is a massive-volume strategic export to surgical hospitals, emergency departments, and international B2B distributors, serving as the globally preferred intervention for severe anaerobic infections where oral administration is not possible.
Product Overview
This formulation operates as a “Cellular Death Trigger.” It physically exploits the unique metabolism of anaerobic organisms to chemically destroy them from within.
Mechanism 1 (Reductive Activation): Metronidazole physically enters the pathogen. In the absence of oxygen, it is chemically reduced to Reactive Intermediates (toxic radicals).
Mechanism 2 (DNA Fragmentation): These radicals physically bind to the Bacterial DNA Helix, chemically causing strand breakage and loss of helical structure, physically leading to immediate cell death.
Mechanism 3 (Protozoal Eradication): It physically targets the electron transport proteins of anaerobic protozoa, chemically halting their energy production and making it the physical choice for treating severe amoebiasis.
Product Composition & Strength
We supply this product as a Sterile, Non-Pyrogenic, Isotonic Solution for intravenous administration.
| Active Ingredient | Strength (per 100 ml) | Primary Clinical Function |
| Metronidazole IP/BP/USP | 500 mg | The Anti-infective: Targets anaerobic bacteria & protozoa. |
| Excipients | Sodium Chloride / Water for Injection | The Vehicle: Ensures isotonicity for safe infusion. |
| Formulation | Ready-to-Use (RTU) | The Standard: Sterile and pyrogen-free. |
Technical & Logistics Specifications
HS Code: 3004.20.19 (Medicaments containing other antibiotics / Antiprotozoals)
CAS Number: 443-48-1 (Metronidazole)
Dosage Form: Intravenous Infusion (IV)
Packaging: 100 ml Self-Collapsible LDPE Bags (FFS Technology) or Glass Bottles. Our specialized packaging ensures 36-month stability in Zone IVb tropical climates.
Manufacturing Authority & Compliance
Aseptic LVP Filling: Our manufacturing process utilizes Automated Large Volume Parenteral Lines with 100% terminal sterilization to ensure the product is physically free from all microbial and particulate matter.
Non-Pyrogenic Testing: Every batch physically undergoes Bacterial Endotoxin Testing (BET) to ensure it is safe for direct entry into the human bloodstream, preventing “Infusion Fever.”
Advanced Form-Fill-Seal (FFS): We utilize FFS Technology, physically preventing any environmental contamination and ensuring a tamper-proof delivery system for hospital surgical wards.
Primary Indications
Surgery: Prophylaxis and treatment of Post-Operative Anaerobic Infections (especially after abdominal or gynaecological surgery).
Gynaecology: Management of Pelvic Inflammatory Disease (PID) and bacterial vaginosis.
Internal Medicine: Treatment of Amoebic Liver Abscess, Giardiasis, and severe Trichomoniasis.
Critical Care: Management of Septicemia involving anaerobic pathogens (e.g., Bacteroides fragilis).
Dosage & Administration
Standard Adult Dose: Typically 500 mg (100 ml) administered every 8 hours (three times daily).
Administration: Must be physically administered by Slow Intravenous Infusion over a period of 30 to 60 minutes.
Compatibility Note: Metronidazole should physically not be mixed with other medications in the same infusion bag.
Transition: Once the patient’s condition improves, they are physically transitioned to oral Metronidazole tablets.
Safety Warning: For Intravenous Infusion Only. Alcohol Note: Patients must physically avoid Alcohol during and for 48 hours after treatment to prevent a “Disulfiram-like reaction” (nausea, vomiting, flushing). Neurology Note: Use with caution in patients with active CNS disease. Contraindication: Do not use in patients with known hypersensitivity to Metronidazole or other nitroimidazoles.
Global Export & Contract Manufacturing
Healthy Inc is a premier Anti-Infective and Critical Care Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for high-volume Metronidazole IV infusions. Whether you are a National Health Tender in Africa or a B2B Pharma Marketplace partner in the CIS or SE Asia, we ensure secure, WHO-GMP compliant delivery.